Trial intelligence / Profile preview

Cyclosporine A Metabolites and Acute Renal Failure in Heart Transplant

NCT00264355Phase 4Completed

Sponsor
University of Oslo School of Pharmacy
Start
Dec 2005
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cyclosporine in heart transplant rejection, sponsored by University of Oslo School of Pharmacy. Started Dec 2005; status: completed.

02

Drugs

cyclosporine
03

Conditions

heart transplant rejection

Beyond the preview

Go deeper on NCT00264355.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00264355.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call